The IDEAL4RWE programme has been able to draw on the guidance and advice of a distinguished Leadership Advisory Board (LAB).
This group has advised on the design and implementation of the programme, and overseen the evaluation of studies and disbursement of funding.
The LAB has also provided direct training and advice to individuals and teams.
The LAB members have generously shared their time and insight and are very much appreciated.
David Cameron is Professor of Oncology and Director of Cancer Services at NHS Lothian.He has worked extensively in cancer research, and has a particular interest in the use of routine clinical data to improve partien care through his current role as director of the Scottish Government funded Innovative Health Care Delivery Programma (IHDP).
Iwona Lugowska is the Head of Early Phase Clinical Trials Unit at Maria Sklodowska Curie National Research Institute of Oncology.Her research interests include precision oncology and decision support systems for cancer partients. She also has a strong interest in leadership development, having been a member of the first cohort of the EORTC Early Career Programme in 2018/9.
Massimo Di Maio is Professor of Medical Oncology at Department of Oncology, University of Turin.He has deep experience of cancer research, with particular interest in the methodology of clinical trials and in the study of patient reported outcomes (PROs), both in clinical research and in clinical practice.
Janne Vehreschild is a practicing haemato-oncologist, with an interest in infection research.He has led multiple real world studies, in particular, over the past two years, into COVID-19, and led the setup of the European Registry for Coronavirus Patients.
Sue Cheeseman is a practicing oncologist and active researcher in oncology RWE.She is a pivotal figure in the REAL-Oncology alliance at Leeds Teaching Hospital, and she has published extensively on real world research in multiple tumor types.
Anne-Sophie Hamy-Petit is a medical gynaecologist-oncologist and assistant professor at the university of Paris. She has worked extensively in bio-informatics and real world research.
Andre Dekker is a Professor of Clinical Data Science at Maastricht University Medical Centre and a board certified Medical Physicist. His areas of interest include: building global data sharing infrastructures, and applying artificial intelligence to the improvement of patient care.
Gilliosa Spurrier-Bernard is Vice-Chair of WECAN (the Workgroup of European Cancer Patient Advocacy Network) and an experienced patient advocate in melanoma. She is passionate about the importance of patient involvement in cancer research.
Mariana Guergova-Kuras is an expert in data science and precision medicine. She currently works at IQVIA, supporting international real world evidence generation in cancer - most recently supporting a multi-country ovarian cancer outcomes study.
James Anderson has worked extensively in healthcare, both in the NHS and the private sector.In recent years he has supported life sciences companies in innovative uses of real world evience in oncology, such as external comparators. He has a particular interest in people development, having previously run training prorammes in the public and private sector, and is currently qualifying to become an executive coach.